Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
Raghavendra Rao, General Surgeon at Vein Clinic, Founder of Best Surgical Education, LLC, shared a post on LinkedIn about a recent article by Maciej Wołkowski et al, published in JVS-VL, adding:
“Concomitant foam sclerotherapy of tributaries after truncal ablation with EVLA results in better varicose vein regression at 3 months in the short term and may result in a better quality of life at 6 months.
This comes at the cost of using too much or too concentrated sclerosant, resulting in foam sclerotherapy complications.
Non-randomized study published recently in JVS-VL.
The controversy continues regarding the need for tributary management after EVLA of the truncal veins, but a good percentage seem to need further treatments.
EVLA does have a substantial effect on tributary varicose veins.”
Title: Clinical trial of concomitant versus staged foam sclerotherapy of varicose veins following axial thermal ablation.
Authors: Maciej Wołkowski, Tomasz Urbanek, Krzysztof Wołkowski, Grzegorz Biolik, Wacław Kuczmik

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing
-
Nov 19, 2026, 14:19Long-Read Sequencing Is Closing Diagnostic Gaps in Inherited Bleeding Disorders
-
Nov 19, 2026, 13:36Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy
-
Nov 19, 2026, 13:26M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa
-
Nov 19, 2026, 13:18Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
-
Nov 19, 2026, 13:11When Postpartum Warning Signs Are Ignored – National Blood Clot Alliance